Document is current
Any future updates will be listed below
-
Authors
Budillon, Alberto https://orcid.org/0009-0006-0889-4784
Lemmers, Richard J. L. F. https://orcid.org/0000-0002-7102-710X
Tapscott, Stephen J. https://orcid.org/0000-0002-0319-0968
van der Maarel, Silvère M. https://orcid.org/0000-0001-8103-711X
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01AR045203)
- License Information
-
More Information
Article History
Received: 7 April 2025
Accepted: 29 May 2026
First Online: 5 June 2026
Competing interests
: The authors declare the following competing interests: SMvdM and SJT are Board members of Renogenyx and have acted as consultants and/or advisory board members for several pharmaceutical companies developing therapeutics for FSHD. SMvdM, SJT and RJLFL are co-inventors on several FSHD-related patent applications. AB declares no competing interests.
